Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02627963 · BASELINE

Baseline characteristics

A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) · Source last updated 2023-07-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      175
    2. group Id
      BG001
      value
      175
    3. group Id
      BG002
      value
      350
    units
    Participants
groups
  1. description
    Participants randomized to this arm received the study drug, tivozanib hydrochloride.
    id
    BG000
    title
    Tivozanib Hydrochloride
  2. description
    Participants randomized to this arm received the comparator drug, sorafenib.
    id
    BG001
    title
    Sorafenib
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          34
          upper Limit
          88
          value
          62
        2. group Id
          BG001
          lower Limit
          30
          upper Limit
          90
          value
          63
        3. group Id
          BG002
          lower Limit
          30
          upper Limit
          90
          value
          63
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          49
        2. group Id
          BG001
          value
          47
        3. group Id
          BG002
          value
          96
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          126
        2. group Id
          BG001
          value
          128
        3. group Id
          BG002
          value
          254
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          165
        2. group Id
          BG001
          value
          167
        3. group Id
          BG002
          value
          332
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          10
        2. group Id
          BG001
          value
          8
        3. group Id
          BG002
          value
          18
        title
        Non-white
      title
      Race
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          79
        2. group Id
          BG001
          value
          80
        3. group Id
          BG002
          value
          159
        title
        Two VEGFR TKIs
      2. measurements
        1. group Id
          BG000
          value
          47
        2. group Id
          BG001
          value
          44
        3. group Id
          BG002
          value
          91
        title
        Checkpoint inhibitor plus VEGFR TKI
      3. measurements
        1. group Id
          BG000
          value
          49
        2. group Id
          BG001
          value
          51
        3. group Id
          BG002
          value
          100
        title
        VEGFR TKI plus other systemic agent
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Previous therapies
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          70
        title
        Favourable
      2. measurements
        1. group Id
          BG000
          value
          109
        2. group Id
          BG001
          value
          105
        3. group Id
          BG002
          value
          214
        title
        Intermediate
      3. measurements
        1. group Id
          BG000
          value
          32
        2. group Id
          BG001
          value
          34
        3. group Id
          BG002
          value
          66
        title
        Poor
    param Type
    COUNT_OF_PARTICIPANTS
    title
    IMDC risk category
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      175
    2. group Id
      BG001
      value
      175
    3. group Id
      BG002
      value
      350
    units
    Participants
groups
  1. description
    Participants randomized to this arm received the study drug, tivozanib hydrochloride.
    id
    BG000
    title
    Tivozanib Hydrochloride
  2. description
    Participants randomized to this arm received the comparator drug, sorafenib.
    id
    BG001
    title
    Sorafenib
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          34
          upper Limit
          88
          value
          62
        2. group Id
          BG001
          lower Limit
          30
          upper Limit
          90
          value
          63
        3. group Id
          BG002
          lower Limit
          30
          upper Limit
          90
          value
          63
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          49
        2. group Id
          BG001
          value
          47
        3. group Id
          BG002
          value
          96
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          126
        2. group Id
          BG001
          value
          128
        3. group Id
          BG002
          value
          254
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          165
        2. group Id
          BG001
          value
          167
        3. group Id
          BG002
          value
          332
        title
        White
      2. measurements
        1. group Id
          BG000
          value
          10
        2. group Id
          BG001
          value
          8
        3. group Id
          BG002
          value
          18
        title
        Non-white
      title
      Race
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          79
        2. group Id
          BG001
          value
          80
        3. group Id
          BG002
          value
          159
        title
        Two VEGFR TKIs
      2. measurements
        1. group Id
          BG000
          value
          47
        2. group Id
          BG001
          value
          44
        3. group Id
          BG002
          value
          91
        title
        Checkpoint inhibitor plus VEGFR TKI
      3. measurements
        1. group Id
          BG000
          value
          49
        2. group Id
          BG001
          value
          51
        3. group Id
          BG002
          value
          100
        title
        VEGFR TKI plus other systemic agent
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Previous therapies
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        2. group Id
          BG001
          value
          36
        3. group Id
          BG002
          value
          70
        title
        Favourable
      2. measurements
        1. group Id
          BG000
          value
          109
        2. group Id
          BG001
          value
          105
        3. group Id
          BG002
          value
          214
        title
        Intermediate
      3. measurements
        1. group Id
          BG000
          value
          32
        2. group Id
          BG001
          value
          34
        3. group Id
          BG002
          value
          66
        title
        Poor
    param Type
    COUNT_OF_PARTICIPANTS
    title
    IMDC risk category
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice